Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Cramer, JA
   Assessing the severity of seizures and epilepsy: which scales are valid?
   CURRENT OPINION IN NEUROLOGY
   
   J.A. Cramer, "Assessing the severity of seizures and epilepsy: which scales are valid?", CURR OP NEU, 14(2), 2001, pp. 225-229
2. Panayiotopoulos, CP; Ferrie, CD; Koutroumanidis, M; Rowlinson, S; Sanders, S
   Idiopathic generalised epilepsy with phantom absences and absence status in a child
   EPILEPTIC DISORDERS
   
   C.P. Panayiotopoulos et al., "Idiopathic generalised epilepsy with phantom absences and absence status in a child", EPILEPT DIS, 3(2), 2001, pp. 63-66
3. Brodie, MJ; Kwan, P
   The Star Systems - Overview and use in determining antiepileptic drug choice
   CNS DRUGS
   
   M.J. Brodie e P. Kwan, "The Star Systems - Overview and use in determining antiepileptic drug choice", CNS DRUGS, 15(1), 2001, pp. 1-12
4. Anderson, GD; Miller, JW
   The newer antiepileptic drugs: Their collective role and defining characteristics
   FORMULARY
   
   G.D. Anderson e J.W. Miller, "The newer antiepileptic drugs: Their collective role and defining characteristics", FORMULARY, 36(2), 2001, pp. 114
5. Bonanno, DG; Davydov, L; Botts, SR
   Olanzapine-induced diabetes mellitus
   ANNALS OF PHARMACOTHERAPY
   
   D.G. Bonanno et al., "Olanzapine-induced diabetes mellitus", ANN PHARMAC, 35(5), 2001, pp. 563-565
6. MacDonald, B
   The prognosis of epilepsy
   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
   
   B. MacDonald, "The prognosis of epilepsy", SEIZURE-E J, 10(5), 2001, pp. 347-358
7. Bell, GS; Sander, JW
   The epidemiology of epilepsy: the size of the problem
   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
   
   G.S. Bell e J.W. Sander, "The epidemiology of epilepsy: the size of the problem", SEIZURE-E J, 10(4), 2001, pp. 306-316
8. Cramer, JA; Ben Menachem, E; French, J
   Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation
   EPILEPSY RESEARCH
   
   J.A. Cramer et al., "Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation", EPILEPSY R, 47(1-2), 2001, pp. 17-25
9. French, J; Edrich, P; Cramer, JA
   A systematic review of the safety profile of levetiracetam: a new antiepileptic drug
   EPILEPSY RESEARCH
   
   J. French et al., "A systematic review of the safety profile of levetiracetam: a new antiepileptic drug", EPILEPSY R, 47(1-2), 2001, pp. 77-90
10. Ben-Menachem, E
    Proof of efficacy trials: seizure types
    EPILEPSY RESEARCH
    
    E. Ben-Menachem, "Proof of efficacy trials: seizure types", EPILEPSY R, 45(1-3), 2001, pp. 31-34
11. Mattson, RH
    Monotherapy trials: endpoints
    EPILEPSY RESEARCH
    
    R.H. Mattson, "Monotherapy trials: endpoints", EPILEPSY R, 45(1-3), 2001, pp. 109-117
12. Holland, KD
    Efficacy, pharmacology, and adverse effects of antiepileptic drugs
    NEUROLOGIC CLINICS
    
    K.D. Holland, "Efficacy, pharmacology, and adverse effects of antiepileptic drugs", NEUROL CLIN, 19(2), 2001, pp. 313
13. Wheless, JW; Baumgartner, J; Ghanbari, C
    Vagus nerve stimulation and the ketogenic diet
    NEUROLOGIC CLINICS
    
    J.W. Wheless et al., "Vagus nerve stimulation and the ketogenic diet", NEUROL CLIN, 19(2), 2001, pp. 371
14. Schachter, SC
    Epilepsy
    NEUROLOGIC CLINICS
    
    S.C. Schachter, "Epilepsy", NEUROL CLIN, 19(1), 2001, pp. 57
15. Oguni, H; Hayashi, K; Awaya, Y; Fukuyama, Y; Osawa, M
    Severe myoclonic epilepsy in infants - a review based on the Tokyo Women'sMedical University series of 84 cases
    BRAIN & DEVELOPMENT
    
    H. Oguni et al., "Severe myoclonic epilepsy in infants - a review based on the Tokyo Women'sMedical University series of 84 cases", BRAIN DEVEL, 23(7), 2001, pp. 736-748
16. Takahashi, S; Takahashi, Y; Kondo, N; Orii, T
    Epileptic seizures and structural abnormalities in a patient with holoprosencephaly
    BRAIN & DEVELOPMENT
    
    S. Takahashi et al., "Epileptic seizures and structural abnormalities in a patient with holoprosencephaly", BRAIN DEVEL, 23(4), 2001, pp. 264-268
17. Dixit, RK; Chawla, AB; Kumar, N; Garg, SK
    Effect of omeprazole on the pharmacokinetics of sustained-release carbamazepine in healthy male volunteers
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    
    R.K. Dixit et al., "Effect of omeprazole on the pharmacokinetics of sustained-release carbamazepine in healthy male volunteers", METH FIND E, 23(1), 2001, pp. 37-39
18. Vathy, I
    Prenatal morphine exposure induces age- and sex-dependent changes in seizure susceptibility
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    
    I. Vathy, "Prenatal morphine exposure induces age- and sex-dependent changes in seizure susceptibility", PROG NEUR-P, 25(6), 2001, pp. 1203-1226
19. Glauser, TA
    Oxcarbazepine in the treatment of epilepsy
    PHARMACOTHERAPY
    
    T.A. Glauser, "Oxcarbazepine in the treatment of epilepsy", PHARMACOTHE, 21(8), 2001, pp. 904-919
20. Mani, KS; Rangan, G; Srinivas, HV; Srindharan, VS; Subbakrishna, DK
    Epilepsy control with phenobarbital or phenytoin in rural south India: theYelandur study
    LANCET
    
    K.S. Mani et al., "Epilepsy control with phenobarbital or phenytoin in rural south India: theYelandur study", LANCET, 357(9265), 2001, pp. 1316-1320
21. McLean, A; Browne, S; Zhang, YX; Slaughter, E; Halstenson, C; Couch, R
    The influence of food on the bioavailability of a twice-daily controlled release carbamazepine formulation
    JOURNAL OF CLINICAL PHARMACOLOGY
    
    A. McLean et al., "The influence of food on the bioavailability of a twice-daily controlled release carbamazepine formulation", J CLIN PHAR, 41(2), 2001, pp. 183-186
22. Browne, TR; Holmes, GL
    Primary care: Epilepsy.
    NEW ENGLAND JOURNAL OF MEDICINE
    
    T.R. Browne e G.L. Holmes, "Primary care: Epilepsy.", N ENG J MED, 344(15), 2001, pp. 1145-1151
23. Rosenow, F; Hamer, HM; Knake, S; Katsarou, N; Fritsch, B; Oertel, WH; Shiratori, K; Luders, HO
    Lateralising and localising signs and symptoms of epileptic seizures - Applications for clinical evaluation of epileptic patients
    NERVENARZT
    
    F. Rosenow et al., "Lateralising and localising signs and symptoms of epileptic seizures - Applications for clinical evaluation of epileptic patients", NERVENARZT, 72(10), 2001, pp. 743-749
24. Thomas, SV; Sarma, PS; Alexander, M; Pandit, L; Shekhar, L; Trivedi, C; Vengamma, B
    Epilepsy care in six Indian cities: a multicenter study on management and service
    JOURNAL OF THE NEUROLOGICAL SCIENCES
    
    S.V. Thomas et al., "Epilepsy care in six Indian cities: a multicenter study on management and service", J NEUR SCI, 188(1-2), 2001, pp. 73-77
25. Tatum, WO; French, JA; Faught, E; Morris, GL; Liporace, J; Kanner, A; Goff, SL; Winters, L; Fix, A
    Postmarketing experience with topiramate and cognition
    EPILEPSIA
    
    W.O. Tatum et al., "Postmarketing experience with topiramate and cognition", EPILEPSIA, 42(9), 2001, pp. 1134-1140
26. Kwan, P; Brodie, MJ
    Effectiveness of first antiepileptic drug
    EPILEPSIA
    
    P. Kwan e M.J. Brodie, "Effectiveness of first antiepileptic drug", EPILEPSIA, 42(10), 2001, pp. 1255-1260
27. Leppik, IE
    Issues in the treatment of epilepsy
    EPILEPSIA
    
    I.E. Leppik, "Issues in the treatment of epilepsy", EPILEPSIA, 42, 2001, pp. 1-6
28. Rosenow, F; Luders, H
    Presurgical evaluation of epilepsy
    BRAIN
    
    F. Rosenow e H. Luders, "Presurgical evaluation of epilepsy", BRAIN, 124, 2001, pp. 1683-1700
29. Malhi, GS; Mitchell, PB; Caterson, I
    'Why getting fat, Doc?' Weight gain and psychotropic medications
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    
    G.S. Malhi et al., "'Why getting fat, Doc?' Weight gain and psychotropic medications", AUST NZ J P, 35(3), 2001, pp. 315-321
30. Dlugos, DJ
    The early identification of candidates for epilepsy surgery
    ARCHIVES OF NEUROLOGY
    
    D.J. Dlugos, "The early identification of candidates for epilepsy surgery", ARCH NEUROL, 58(10), 2001, pp. 1543-1546
31. Trinka, E; Martin, F; Luef, G; Unterberger, I; Bauer, G
    Chronic epilepsy with complex partial seizures is not always medically intractable - a long-term observational study
    ACTA NEUROLOGICA SCANDINAVICA
    
    E. Trinka et al., "Chronic epilepsy with complex partial seizures is not always medically intractable - a long-term observational study", ACT NEUR SC, 103(4), 2001, pp. 219-225
32. Jain, KK
    An assessment of levetiracetam as an anti-epileptic drug
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    K.K. Jain, "An assessment of levetiracetam as an anti-epileptic drug", EXPERT OP I, 9(7), 2000, pp. 1611-1624
33. Leach, JP
    Antiepileptic drugs: safety in numbers?
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
    
    J.P. Leach, "Antiepileptic drugs: safety in numbers?", SEIZURE-E J, 9(3), 2000, pp. 170-178
34. Bourgeois, BFD
    New antiepileptic drugs in children: Which ones for which seizures?
    CLINICAL NEUROPHARMACOLOGY
    
    B.F.D. Bourgeois, "New antiepileptic drugs in children: Which ones for which seizures?", CLIN NEUROP, 23(3), 2000, pp. 119-132
35. Jones, MW; Andermann, F
    Temporal lobe epilepsy surgery: Definition of candidacy
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    
    M.W. Jones e F. Andermann, "Temporal lobe epilepsy surgery: Definition of candidacy", CAN J NEUR, 27, 2000, pp. S11-S13
36. Pellock, JM
    Treatment of epilepsy in the new millennium
    PHARMACOTHERAPY
    
    J.M. Pellock, "Treatment of epilepsy in the new millennium", PHARMACOTHE, 20(8), 2000, pp. 129S-138S
37. Rowan, AJ
    Management of seizures in the elderly
    PHARMACOTHERAPY
    
    A.J. Rowan, "Management of seizures in the elderly", PHARMACOTHE, 20(8), 2000, pp. 178S-184S
38. Garnett, WR
    Antiepileptic drug treatment: Outcomes and adherence
    PHARMACOTHERAPY
    
    W.R. Garnett, "Antiepileptic drug treatment: Outcomes and adherence", PHARMACOTHE, 20(8), 2000, pp. 191S-199S
39. Brodie, MJ; French, JA
    Management of epilepsy in adolescents and adults
    LANCET
    
    M.J. Brodie e J.A. French, "Management of epilepsy in adolescents and adults", LANCET, 356(9226), 2000, pp. 323-329
40. Martinjak-Dvorsek, I; Gorjup, V; Horvat, M; Noc, M
    Acute isoniazid neurotoxicity during preventive therapy
    CRITICAL CARE MEDICINE
    
    I. Martinjak-Dvorsek et al., "Acute isoniazid neurotoxicity during preventive therapy", CRIT CARE M, 28(2), 2000, pp. 567-568
41. Ramsay, RE; Pryor, F
    Epilepsy in the elderly
    NEUROLOGY
    
    R.E. Ramsay e F. Pryor, "Epilepsy in the elderly", NEUROLOGY, 55(5), 2000, pp. S9-S14
42. Sachdeo, R
    Challenging our past paradigm in the management of epilepsy
    NEUROLOGY
    
    R. Sachdeo, "Challenging our past paradigm in the management of epilepsy", NEUROLOGY, 55(11), 2000, pp. S1-S4
43. Devinsky, O; Cramer, J
    Safety and efficacy of standard and new antiepileptic drugs
    NEUROLOGY
    
    O. Devinsky e J. Cramer, "Safety and efficacy of standard and new antiepileptic drugs", NEUROLOGY, 55(11), 2000, pp. S5-S10
44. Glauser, TA
    Expanding first-line therapy options for children with partial seizures
    NEUROLOGY
    
    T.A. Glauser, "Expanding first-line therapy options for children with partial seizures", NEUROLOGY, 55(11), 2000, pp. S30-S37
45. Stefan, H; Froscher, W; Kramer, G; Schmidt, D
    Drug treatment before and after epilepsy surgery - a critical summary and recommendations
    NERVENARZT
    
    H. Stefan et al., "Drug treatment before and after epilepsy surgery - a critical summary and recommendations", NERVENARZT, 71(6), 2000, pp. 451-458
46. Beyenburg, S; Bauer, J; Elger, CE
    Treatment of generalized tonic-clonic status epilepticus in adults
    NERVENARZT
    
    S. Beyenburg et al., "Treatment of generalized tonic-clonic status epilepticus in adults", NERVENARZT, 71(2), 2000, pp. 65-77
47. Meierkord, H; Grunig, F; Gutschmidt, U; Gutierrez, R; Pfeiffer, M; Draguhn, A; Bruckner, C; Heinemann, U
    Sodium bromide: effects on different patterns of epileptiform activity, extracellular pH changes and GABAergic inhibition
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    H. Meierkord et al., "Sodium bromide: effects on different patterns of epileptiform activity, extracellular pH changes and GABAergic inhibition", N-S ARCH PH, 361(1), 2000, pp. 25-32
48. Osorio, I; Reed, RC; Peltzer, JN
    Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine
    EPILEPSIA
    
    I. Osorio et al., "Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine", EPILEPSIA, 41(7), 2000, pp. 887-894
49. Gulgonen, S; Demirbilek, V; Korkmaz, B; Dervent, A; Townes, BD
    Neuropsychological functions in idiopathic occipital lobe epilepsy
    EPILEPSIA
    
    S. Gulgonen et al., "Neuropsychological functions in idiopathic occipital lobe epilepsy", EPILEPSIA, 41(4), 2000, pp. 405-411
50. Kotagal, P; Bleasel, A; Geller, E; Kankirawatana, P; Moorjani, BI; Rybicki, L
    Lateralizing value of asymmetric tonic limb posturing observed in secondarily generalized tonic-clonic seizures
    EPILEPSIA
    
    P. Kotagal et al., "Lateralizing value of asymmetric tonic limb posturing observed in secondarily generalized tonic-clonic seizures", EPILEPSIA, 41(4), 2000, pp. 457-462
51. Harden, CL
    Therapeutic safety monitoring: What to look for and when to look for it
    EPILEPSIA
    
    C.L. Harden, "Therapeutic safety monitoring: What to look for and when to look for it", EPILEPSIA, 41, 2000, pp. S37-S44
52. Greenwood, RS
    Adverse effects of antiepileptic drugs
    EPILEPSIA
    
    R.S. Greenwood, "Adverse effects of antiepileptic drugs", EPILEPSIA, 41, 2000, pp. S42-S52
53. Montouris, GD; Biton, V; Rosenfeld, WE
    Nonfocal generalized tonic-clonic seizures: Response during long-term topiramate treatment
    EPILEPSIA
    
    G.D. Montouris et al., "Nonfocal generalized tonic-clonic seizures: Response during long-term topiramate treatment", EPILEPSIA, 41, 2000, pp. S77-S81
54. Pierre-Louis, SJC
    New drugs: Which should be included in the formulary? Epilepsy: All new drugs should be included
    ARCHIVES OF NEUROLOGY
    
    S.J.C. Pierre-Louis, "New drugs: Which should be included in the formulary? Epilepsy: All new drugs should be included", ARCH NEUROL, 57(2), 2000, pp. 272-273
55. Bauer, J; Saher, MS; Burr, W; Elger, CE
    Precipitating factors and therapeutic outcome in epilepsy with generalizedtonic-clonic seizures
    ACTA NEUROLOGICA SCANDINAVICA
    
    J. Bauer et al., "Precipitating factors and therapeutic outcome in epilepsy with generalizedtonic-clonic seizures", ACT NEUR SC, 102(4), 2000, pp. 205-208
56. Ben-Menachem, E; Henriksen, O; Johannessen, SI
    Diagnosis and treatment of partial seizures
    CNS DRUGS
    
    E. Ben-Menachem et al., "Diagnosis and treatment of partial seizures", CNS DRUGS, 11(1), 1999, pp. 23-39
57. Petroff, OAC; Rothman, DL; Behar, KL; Hyder, F; Mattson, RH
    Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
    
    O.A.C. Petroff et al., "Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures", SEIZURE-E J, 8(2), 1999, pp. 120-127
58. Yegnanarayan, R; Kulkarni, HG; Wadia, RS
    The effect of time of administration of phenytoin on its serum levels and pharmacodynamic parameters in patients of generalised tonic clonic seizures
    BIOLOGICAL RHYTHM RESEARCH
    
    R. Yegnanarayan et al., "The effect of time of administration of phenytoin on its serum levels and pharmacodynamic parameters in patients of generalised tonic clonic seizures", BIOL RH RES, 30(3), 1999, pp. 321-331
59. Regesta, G; Tanganelli, P
    Clinical aspects and biological bases of drug-resistant epilepsies
    EPILEPSY RESEARCH
    
    G. Regesta e P. Tanganelli, "Clinical aspects and biological bases of drug-resistant epilepsies", EPILEPSY R, 34(2-3), 1999, pp. 109-122
60. Perucca, E; Tomson, T
    Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications
    EPILEPSY RESEARCH
    
    E. Perucca e T. Tomson, "Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications", EPILEPSY R, 33(2-3), 1999, pp. 247-262
61. Stephani, U; Diener, W; Ramm, S
    Today's treatment of epilepsy with potassium bromide
    NERVENHEILKUNDE
    
    U. Stephani et al., "Today's treatment of epilepsy with potassium bromide", NERVENHEILK, 18(6), 1999, pp. 311-316
62. Smit, A; Schoeman, JF; Seifart, HI; Parkin, DP
    Practical management of therapeutic diphenylhydantoin concentrations in children
    SOUTH AFRICAN MEDICAL JOURNAL
    
    A. Smit et al., "Practical management of therapeutic diphenylhydantoin concentrations in children", S AFR MED J, 89(10), 1999, pp. 1092-1097
63. Chesson, AL; Wise, M; Davila, D; Johnson, S; Littner, M; Anderson, WM; Hartse, K; Rafecas, J
    Practice parameters for the treatment of Restless Legs Syndrome and periodic limb movement disorder
    SLEEP
    
    A.L. Chesson et al., "Practice parameters for the treatment of Restless Legs Syndrome and periodic limb movement disorder", SLEEP, 22(7), 1999, pp. 961-968
64. Chadwick, D
    Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study
    LANCET
    
    D. Chadwick, "Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study", LANCET, 354(9172), 1999, pp. 13-19
65. Sirven, JI; Varrato, J
    Physical activity and epilepsy - What are the rules?
    PHYSICIAN AND SPORTSMEDICINE
    
    J.I. Sirven e J. Varrato, "Physical activity and epilepsy - What are the rules?", PHYS SPORT, 27(3), 1999, pp. 63
66. Arroyo, S; Sander, JWAS
    Carbamazepine in comparative trials - Pharmacokinetic characteristics too often forgotten
    NEUROLOGY
    
    S. Arroyo e J.W.A.S. Sander, "Carbamazepine in comparative trials - Pharmacokinetic characteristics too often forgotten", NEUROLOGY, 53(6), 1999, pp. 1170-1174
67. Ketter, TA; Post, RM; Theodore, WH
    Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders
    NEUROLOGY
    
    T.A. Ketter et al., "Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders", NEUROLOGY, 53(5), 1999, pp. S53-S67
68. Martin, R; Kuzniecky, R; Ho, S; Hetherington, H; Pan, J; Sinclair, K; Gilliam, F; Faught, E
    Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults
    NEUROLOGY
    
    R. Martin et al., "Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults", NEUROLOGY, 52(2), 1999, pp. 321-327
69. Kadir, ZA; Chadwick, DW
    Principles of treament of epilepsy
    DRUGS OF TODAY
    
    Z.A. Kadir e D.W. Chadwick, "Principles of treament of epilepsy", DRUGS TODAY, 35(1), 1999, pp. 35-41
70. Faught, E
    Clinical studies of topiramate
    DRUGS OF TODAY
    
    E. Faught, "Clinical studies of topiramate", DRUGS TODAY, 35(1), 1999, pp. 49-57
71. Eisenschenk, S; Gilmore, R
    Strategies for successful management of older patients with seizures
    GERIATRICS
    
    S. Eisenschenk e R. Gilmore, "Strategies for successful management of older patients with seizures", GERIATRICS, 54(12), 1999, pp. 31
72. McLean, MJ; Morrell, MJ; Willmore, LJ; Privitera, MD; Faught, RE; Holmes, GL; Magnus-Miller, L; Bernstein, P; Rose-Legatt, A
    Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study
    EPILEPSIA
    
    M.J. McLean et al., "Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study", EPILEPSIA, 40(7), 1999, pp. 965-972
73. Cramer, JA; Fisher, R; Ben-Menachem, E; French, J; Mattson, RH
    New antiepileptic drugs: Comparison of key clinical trials
    EPILEPSIA
    
    J.A. Cramer et al., "New antiepileptic drugs: Comparison of key clinical trials", EPILEPSIA, 40(5), 1999, pp. 590-600
74. Radhakrishnan, K; Nayak, SD; Kumar, SP; Sarma, PS
    Profile of antiepileptic pharmacotherapy in a tertiary referral center in South India: A pharmacoepidemiologic and pharmacoeconomic study
    EPILEPSIA
    
    K. Radhakrishnan et al., "Profile of antiepileptic pharmacotherapy in a tertiary referral center in South India: A pharmacoepidemiologic and pharmacoeconomic study", EPILEPSIA, 40(2), 1999, pp. 179-185
75. Privitera, MD
    Evidence-based medicine and antiepileptic drugs
    EPILEPSIA
    
    M.D. Privitera, "Evidence-based medicine and antiepileptic drugs", EPILEPSIA, 40, 1999, pp. S47-S56
76. Lowenstein, DH
    Status epilepticus: An overview of the clinical problem
    EPILEPSIA
    
    D.H. Lowenstein, "Status epilepticus: An overview of the clinical problem", EPILEPSIA, 40, 1999, pp. S3-S8
77. Chadwick, D
    Does withdrawal of different antiepileptic drugs have different effects onseizure recurrence? Further results from the MRC Antiepileptic Drug Withdrawal Study
    BRAIN
    
    D. Chadwick, "Does withdrawal of different antiepileptic drugs have different effects onseizure recurrence? Further results from the MRC Antiepileptic Drug Withdrawal Study", BRAIN, 122, 1999, pp. 441-448
78. Engel, J
    The timing of surgical intervention for mesial temporal lobe epilepsy - A plan for a randomized clinical trial
    ARCHIVES OF NEUROLOGY
    
    J. Engel, "The timing of surgical intervention for mesial temporal lobe epilepsy - A plan for a randomized clinical trial", ARCH NEUROL, 56(11), 1999, pp. 1338-1341
79. MULLENS EL
    CLINICAL-EXPERIENCE WITH LAMOTRIGINE MONOTHERAPY IN ADULTS WITH NEWLY-DIAGNOSED EPILEPSY - A REVIEW OF PUBLISHED RANDOMIZED CLINICAL-TRIALS
    Clinical drug investigation
    
    E.L. Mullens, "CLINICAL-EXPERIENCE WITH LAMOTRIGINE MONOTHERAPY IN ADULTS WITH NEWLY-DIAGNOSED EPILEPSY - A REVIEW OF PUBLISHED RANDOMIZED CLINICAL-TRIALS", Clinical drug investigation, 16(2), 1998, pp. 125-133
80. GRAVES NM; GIDAL BE; GILLIAM FG
    THE NEW-GENERATION OF ANTIEPILEPTIC DRUGS - UNRESOLVED QUESTIONS
    The Annals of pharmacotherapy
    
    N.M. Graves et al., "THE NEW-GENERATION OF ANTIEPILEPTIC DRUGS - UNRESOLVED QUESTIONS", The Annals of pharmacotherapy, 32(11), 1998, pp. 1239-1243
81. PARK SA; LEE BI; PARK SC; LEE SJ; KIM WJ; LEE JH; KIM JY
    CLINICAL COURSES OF PURE SLEEP EPILEPSIES
    Seizure (London)
    
    S.A. Park et al., "CLINICAL COURSES OF PURE SLEEP EPILEPSIES", Seizure (London), 7(5), 1998, pp. 369-377
82. MURTHY JMK; RAO CM; MEENA AK
    CLINICAL OBSERVATIONS OF JUVENILE MYOCLONIC EPILEPSY IN 131 PATIENTS - A STUDY IN SOUTH-INDIA
    Seizure
    
    J.M.K. Murthy et al., "CLINICAL OBSERVATIONS OF JUVENILE MYOCLONIC EPILEPSY IN 131 PATIENTS - A STUDY IN SOUTH-INDIA", Seizure, 7(1), 1998, pp. 43-47
83. Baldy-Moulinier, M; Covanis, A; D'Urso, S; Eskazan, E; Fattore, C; Gatti, G; Herranz, JL; Ibrahim, S; Khalifa, A; Mrabet, A; Neufeld, MY; Perucca, E
    Therapeutic strategies against epilepsy in Mediterranean countries: a report from an international collaborative survey
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
    
    M. Baldy-Moulinier et al., "Therapeutic strategies against epilepsy in Mediterranean countries: a report from an international collaborative survey", SEIZURE-E J, 7(6), 1998, pp. 513-520
84. PREVEY ML; DELANEY RC; CRAMER JA; MATTSON RH
    COMPLEX PARTIAL AND SECONDARILY GENERALIZED SEIZURE PATIENTS - COGNITIVE-FUNCTIONING PRIOR TO TREATMENT WITH ANTIEPILEPTIC MEDICATION
    Epilepsy research
    
    M.L. Prevey et al., "COMPLEX PARTIAL AND SECONDARILY GENERALIZED SEIZURE PATIENTS - COGNITIVE-FUNCTIONING PRIOR TO TREATMENT WITH ANTIEPILEPTIC MEDICATION", Epilepsy research, 30(1), 1998, pp. 1-9
85. CRAMER JA
    SEIZURE MEASUREMENT IN CLINICAL-TRIALS
    Journal of epilepsy
    
    J.A. Cramer, "SEIZURE MEASUREMENT IN CLINICAL-TRIALS", Journal of epilepsy, 11(5), 1998, pp. 256-260
86. LERMANSAGIE T; LERMAN P
    DRAMATIC EFFECT OF LAMOTRIGINE IN YOUNG-ADULTS SUFFERING FROM INTRACTABLE ABSENCES AND GENERALIZED TONIC-CLONIC SEIZURES SINCE CHILDHOOD
    Journal of epilepsy
    
    T. Lermansagie e P. Lerman, "DRAMATIC EFFECT OF LAMOTRIGINE IN YOUNG-ADULTS SUFFERING FROM INTRACTABLE ABSENCES AND GENERALIZED TONIC-CLONIC SEIZURES SINCE CHILDHOOD", Journal of epilepsy, 11(3), 1998, pp. 148-151
87. Petersen, B; Walker, ML; Runge, U; Kessler, C
    Quality of life in patients with idiopathic, generalized epilepsy
    JOURNAL OF EPILEPSY
    
    B. Petersen et al., "Quality of life in patients with idiopathic, generalized epilepsy", J EPILEPSY, 11(6), 1998, pp. 306-313
88. Gueguen, B
    Refractory epilepsies
    PRESSE MEDICALE
    
    B. Gueguen, "Refractory epilepsies", PRESSE MED, 27(39), 1998, pp. 2036-2042
89. BAUER J
    ANTIEPILEPTIC POLYTHERAPY - RATIONAL CONCEPTS VERSUS PROVEN EFFICACY
    Fortschritte der Neurologie, Psychiatrie
    
    J. Bauer, "ANTIEPILEPTIC POLYTHERAPY - RATIONAL CONCEPTS VERSUS PROVEN EFFICACY", Fortschritte der Neurologie, Psychiatrie, 66(9), 1998, pp. 414-426
90. DIENER W; SORNI M; RUILE S; RUDE P; KRUSE R; BECKER E; BORK K; BERG PA
    PANNICULITIS DUE TO POTASSIUM-BROMIDE
    Brain & development
    
    W. Diener et al., "PANNICULITIS DUE TO POTASSIUM-BROMIDE", Brain & development, 20(2), 1998, pp. 83-87
91. EELLS JB; CLOUGH RW; BROWNING RA
    EXPRESSION OF FOS IN THE SUPERIOR LATERAL SUBDIVISION OF THE LATERAL PARABRACHIAL (LPBSL) AREA AFTER GENERALIZED TONIC SEIZURES IN RATS
    Brain research bulletin
    
    J.B. Eells et al., "EXPRESSION OF FOS IN THE SUPERIOR LATERAL SUBDIVISION OF THE LATERAL PARABRACHIAL (LPBSL) AREA AFTER GENERALIZED TONIC SEIZURES IN RATS", Brain research bulletin, 47(2), 1998, pp. 155-161
92. GUBERMAN A
    MONOTHERAPY OR POLYTHERAPY FOR EPILEPSY
    Canadian journal of neurological sciences
    
    A. Guberman, "MONOTHERAPY OR POLYTHERAPY FOR EPILEPSY", Canadian journal of neurological sciences, 25(4), 1998, pp. 3-8
93. SCHNEIDERMAN JH
    MONOTHERAPY VERSUS POLYTHERAPY IN EPILEPSY - A FRAMEWORK FOR PATIENT-MANAGEMENT
    Canadian journal of neurological sciences
    
    J.H. Schneiderman, "MONOTHERAPY VERSUS POLYTHERAPY IN EPILEPSY - A FRAMEWORK FOR PATIENT-MANAGEMENT", Canadian journal of neurological sciences, 25(4), 1998, pp. 9-13
94. DOOSE H; LUNAU H; CASTIGLIONE E; WALTZ S
    SEVERE IDIOPATHIC GENERALIZED EPILEPSY OF INFANCY WITH GENERALIZED TONIC-CLONIC SEIZURES
    Neuropediatrics
    
    H. Doose et al., "SEVERE IDIOPATHIC GENERALIZED EPILEPSY OF INFANCY WITH GENERALIZED TONIC-CLONIC SEIZURES", Neuropediatrics, 29(5), 1998, pp. 229-238
95. Brodtkorb, E
    Antiepileptic drug treatment: Clinical considerations and concerns
    GLUTAMATE SYNAPSE AS A THERAPEUTICAL TARGET: MOLECULAR ORGANIZATION AND PATHOLOGY OF THE GLUTAMATE SYNAPSE
    
    E. Brodtkorb, "Antiepileptic drug treatment: Clinical considerations and concerns", PROG BRAIN, 116, 1998, pp. 395-406
96. PERUCCA E
    INNOVATIVE MONOTHERAPY TRIAL DESIGNS FOR THE ASSESSMENT OF ANTIEPILEPTIC DRUGS - A CRITICAL-APPRAISAL
    European Journal of Clinical Pharmacology
    
    E. Perucca, "INNOVATIVE MONOTHERAPY TRIAL DESIGNS FOR THE ASSESSMENT OF ANTIEPILEPTIC DRUGS - A CRITICAL-APPRAISAL", European Journal of Clinical Pharmacology, 54(1), 1998, pp. 1-5
97. MATTSON RH
    MEDICAL-MANAGEMENT OF EPILEPSY IN ADULTS
    Neurology
    
    R.H. Mattson, "MEDICAL-MANAGEMENT OF EPILEPSY IN ADULTS", Neurology, 51(5), 1998, pp. 15-20
98. LEPPIK IE
    THE ROLE OF LAMOTRIGINE IN THE TREATMENT OF EPILEPSY
    Neurology
    
    I.E. Leppik, "THE ROLE OF LAMOTRIGINE IN THE TREATMENT OF EPILEPSY", Neurology, 51(4), 1998, pp. 940-942
99. GILLIAM F; VAZQUEZ B; SACKELLARES JC; CHANG GY; MESSENHEIMER J; NYBERG J; RISNER ME; RUDD GD
    AN ACTIVE-CONTROL TRIAL OF LAMOTRIGINE MONOTHERAPY FOR PARTIAL SEIZURES
    Neurology
    
    F. Gilliam et al., "AN ACTIVE-CONTROL TRIAL OF LAMOTRIGINE MONOTHERAPY FOR PARTIAL SEIZURES", Neurology, 51(4), 1998, pp. 1018-1025
100. Mirza, WU; Rak, IW; Thadani, VM; Cereghino, JJ; Garnett, WR; Brown, LM; Zhang, Y; Belendiuk, CW
     Six-month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures
     NEUROLOGY
     
     W.U. Mirza et al., "Six-month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures", NEUROLOGY, 51(6), 1998, pp. 1727-1729